Ownership

Andrew Murphy - EVP Research at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: EVP Research
Stock Symbol: REGN on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Andrew Murphy - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-12.1K	100%	$1,059.51	-$12.9M
Net	-12.1K	-100%		-$12.9M

Holdings reported by Andrew Murphy for Regeneron Pharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	49.1K	$35.9M	$730.81	Dec 16, 2024	Direct
Common Stock	4.33K	$3.16M	$730.81	Dec 16, 2024	By 401(k) Plan
Non-Qualified Stock Option (right to buy)	20K			Mar 13, 2024	Direct	Common Stock
Non-Qualified Stock Option (right to buy)	13.5K			Dec 6, 2024	Direct	Common Stock

Transactions reported by Andrew Murphy for Regeneron Pharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.